-
Mashup Score: 13
Learn about our metastatic breast cancer support and education at Dana-Farber Cancer Institute today.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Cancer Questions | Dana-Farber Cancer Institute - 2 month(s) ago
Cancer Questions is a podcast by Dana-Farber Cancer Institute that addresses some of the most common questions surrounding cancer risk and prevention.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 57Toni Choueiri, MD - Dana-Farber Cancer Institute | Boston, MA - 3 month(s) ago
Toni Choueiri, MD – Medical Oncology
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our Editor Spotlight this week is Toni Choueiri, MD (@DrChoueiri), Chief @DanaFarber_GU, Prof. @Harvard and Associate Editor @ESMO_Open. Dr. Choueiri focuses his research on the development of novel drugs and biomarkers for RCC and other GU malignancies. https://t.co/XoR5Y9M4Jh https://t.co/2cqt6XpMvT
-
-
Mashup Score: 6More than 125 Dana-Farber affiliated faculty named as 2024 Top Doctors™ in Boston Magazine | Dana-Farber Cancer Institute - 3 month(s) ago
Boston magazine has named more than 125 physicians affiliated with Dana-Farber Cancer Institute to its annual “Top Doctors” guide.
Source: www.dana-farber.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30Sara M. Tolaney, MD, MPH - Dana-Farber Cancer Institute | Boston, MA - 3 month(s) ago
Sara M. Tolaney, MD, MPH – Medical Oncology
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our Editor Spotlight this week is Sara Tolaney, MD, MPH, Chief of @DFCI_BreastOnc and Associate Editor for breast cancer at @ESMO_Open. Dr. Tolaney has pioneered treatment tailoring for HER2+ BC, and focuses her research on new drugs for all BC subtypes. https://t.co/LfenEwywmk https://t.co/nHHxEtWz1m
-
-
Mashup Score: 28Immunotherapy post-surgery improves overall survival for kidney cancer | Dana-Farber Cancer Institute - 3 month(s) ago
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
"Since 1973, more than 12,000 patients with #kidneycancer participated in adjuvant studies versus a control arm and none of the studies showed the experimental arm extends lives until now with the KEYNOTE-564 study," says @DrChoueiri. Continue Reading: https://t.co/VGQ2adqoIF https://t.co/bKuQGGssQj
-
-
Mashup Score: 24Cancer Questions | Dana-Farber Cancer Institute - 3 month(s) ago
Cancer Questions is a podcast by Dana-Farber Cancer Institute that addresses some of the most common questions surrounding cancer risk and prevention.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Marshfield resident Ralph "Rocco" Russo celebrates 550th platelet donation | Dana-Farber Cancer Institute - 3 month(s) ago
Ralph “Rocco” Russo recently made his 550th platelet donation at Kraft Family Blood Donor Center, which is celebrating its 40th anniversary providing lifesaving blood products to patients at Dana-Farber Cancer Institute and Brigham and Women’s Hospital.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Dana-Farber social worker enables young adult with cancer to reconnect with lifelong passion | Dana-Farber Cancer Institute - 4 month(s) ago
For 32-year-old Clinton Clark III, the most debilitating effect of his treatment for metastasized esophageal cancer has been fatigue that has impacted his ability to pursue many activities he enjoys. Yet through a grant coordinated by a caregiver at Dana-Farber Cancer Institute, he has been able to reconnect with his lifelong passion for art on his own terms.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
For Clinton, the most debilitating effect of his treatment for metastasized #esophagealcancer has been fatigue which has impacted his ability to pursue many activities. Through a grant coordinated by a caregiver, he has been able to reconnect with art. https://t.co/0Em4fGVbit https://t.co/Uz08I0xVQw
-
-
Mashup Score: 23Cancer Questions | Dana-Farber Cancer Institute - 4 month(s) ago
Cancer Questions is a podcast by Dana-Farber Cancer Institute that addresses some of the most common questions surrounding cancer risk and prevention.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
Join us 1/19 1:30 – 2:30 p.m. for a 2023 @SABCSSanAntonio Update on MBC with Hal Burstein, MD, PhD, (@DrHBurstein) part of the EMBRACE Metastatic Breast Cancer Virtual Forum Series. A Q&A will follow the talk. Register today: https://t.co/ZGZkHdvhLx https://t.co/nbqi10q3Po